The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 40 | — | 20.1x | Near average | |
Growth | 63 | 450.6% | 5.6% | Near average | |
Quality | 97 | 190.3% | 7.6% | Above average | |
Safety | 37 | -0.2x | 0.4x | Near average | |
Capital Return | 29 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Cytokinetics, Incorporated is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Cytokinetics, Incorporated shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Cytokinetics stock shows a state of complete stability in the average price target at $99.92 over the past thirty days, with a consensus of 12 analysts without any significant adjustments. This consistency reflects the markets' anticipation of new catalysts, especially with a positive price gap (Upside) of approximately 30% compared to the current price of $76.94, indicating cautious and stable optimism among financial institutions.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.